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 the Editor,
e  thank Dr. Bocanegra et al. for their interest in our study.1
In their comments, they pointed out that the methods sec-
on did not provide the values of phosphorus, calcium, and
H of the patients with and without valvular calciﬁcation
C). Values of these parameters were not shown because we
ecided to include in the table only those values with differ-
ces that were statistically signiﬁcant. Therefore, the values
f phosphorus, being signiﬁcantly different, were shown in
ble 1 of the original article. In our study, the values of cal-
um and PTH were similar in both patient groups, with and
ithout VC, and were within the range recommended by the
DOQI, as shown in Table 1 of this letter.
Regarding the comment on the multivariate analysis of fac-
rs associated with VC, we  would like to offer the following
ariﬁcation: the analysis performed included those variables
at showed a statistically signiﬁcant difference between
oups, including phosphorus. The analysis also included
ther variables that could have been associated with the calci-
cation process: lipids, C-reactive protein, PTH, and calcium,
Please cite this article as: Perales CS, de Castroviejo EVR. Calciﬁcacion
ineral ósea o riesgo cardiovascular previo? Respuesta. Nefrología. 2015
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ough these variables were inadvertently omitted from text.
e  therefore thank Bocanegra et al. for the opportunity to pro-
de this information. The results of the multivariate analysis
owed that older age and lower albumin level were indepen-
ently associated with VC, as shown in Table 3 of the article.
As Bocanegra et al. pointed out, our study demonstrates
at the presence of VC is an independent risk factor for car-
iovascular events and cardiovascular death, although it does
ot establish the factors involved in the development of VC,
ther than older age and lower albumin level. Similarly to
ther studies,2 our study found no association between VC and
e biochemical abnormalities of bone mineral metabolism
at are measured in routine clinical practice. Likewise, there
as no association with atherogenic comorbidities nor withes valvulares en enfermedad renal crónica:¿enfermedad
;35:600–601.
aluated in most of the studies on VC in incident dialysis
atients. In prevalent dialysis patients, VC has been associated
ith a history of cardiovascular events and left ventricular
ypertrophy.3
The precise cellular and molecular mechanisms that
rive cardiac and vascular ectopic calciﬁcation are not fully
,,
e
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Table 1 – Levels of calcium and PTH in patients with and
without valvular calciﬁcation.
Patients without
VC (n = 128)
Patients with
VC (n = 128)
P
Calciuma (mg/dL) 9.28 ± 0.86 9.30 ± 0.94 0.88
PTH (pg/mL) 271.3 ± 263.8 234.5 ± 228.9 0.23
VC, vascular calciﬁcation; PTH, parathyroid hormone.
a Calcium corrected for albumin.
established. Vascular smooth muscle cells and endothelial and
interstitial valvular cells differentiate into osteoblasts with the
ﬁnal result of calciﬁcation. The factors that initiate and pro-
mote mineralisation are both local, related to cellular stress
(oxidative stress, autophagy, apoptosis, etc.) and systemic
(multiple circulating factors).4,5 The overlap between inﬂam-
mation and calciﬁcation is becoming more  and more  evident.
It has been demonstrated in vivo that in atherosclerosis,
inﬁltration by macrophages precedes osteogenic activity,
indicating that macrophages promote a pro-inﬂammatory
environment and send speciﬁc signals to vascular-wall cells
to initiate osteogenic differentiation.5
We  can conclude that in chronic kidney disease, there are
numerous procalcifying factors. Chronic kidney disease leads
to a state of low-grade inﬂammation, cellular stress, and sys-
temic hormonal and bone-mineral metabolism abnormalities,
creating an environment conducive to ectopic calciﬁcation.
Given the complexity of the process, calciﬁcation may require
the simultaneous action of several of these factors. Future
research will provide more  information to add to current
knowledge.
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